NOVAVAX INC
S-3, EX-23.1, 2001-01-04
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NOVAVAX INC, S-3, EX-5.1, 2001-01-04
Next: NOVAVAX INC, S-3, EX-23.2, 2001-01-04



<PAGE>   1
                                                                   EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS


         We hereby consent to the incorporation by reference in this
Registration Statement of Novavax, Inc. on Form S-3 of our report dated
February 26, 2000, relating to the consolidated financial statements which
appears in Novavax, Inc.'s Annual Report on Form 10-K for the year ended
December 31, 1999. We also consent to the reference to us under the heading
"Experts" in such Registration Statement.


/s/ PricewaterhouseCoopers LLP
------------------------------
PricewaterhouseCoopers LLP

McLean, Virginia
January 3, 2001









© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission